Barbara TevelevSenior Scientist Molecular Discovery at Pfizer
Barbara has been part of the Bioprocess Research and Development organization at Pfizer BioPharma for over two decades. She has developed cell lines for production of biosimilars, monoclonal antibodies, vaccines, multi-specifics, and fusions proteins. She has performed phenotypic and genotypic suitability studies for production of commercially viable cell lines and participated in the writing of many INDs. In addition, she has made significant contributions in the last stage arena and authored several BLAs.